Georgiadou et al [45] found that administration of calcitriol and sevelamer in combination restrains the increase of FGF23, indicating that calcitriol’s role in treating osteoporosis may be due to the binding of FGF23. The gene discussed is FGF23; the disease is osteoporosis.